• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.日本鲍曼不动杆菌国际克隆 II 谱系的分布和分子特征。
Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.02190-17. Print 2018 Feb.
2
Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals.来自哥伦比亚医院的耐碳青霉烯鲍曼不动杆菌的独特遗传多样性。
Microb Drug Resist. 2018 Jan/Feb;24(1):48-54. doi: 10.1089/mdr.2016.0190. Epub 2017 Jun 1.
3
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.从马来西亚一家教学医院分离出的多重耐药鲍曼不动杆菌的抗菌耐药机制及遗传多样性
Microb Drug Resist. 2017 Jul;23(5):545-555. doi: 10.1089/mdr.2016.0130. Epub 2016 Nov 17.
4
OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.伊拉克库尔德地区患者临床分离的鲍曼不动杆菌-醋酸钙不动杆菌复合体菌株中存在的OXA-碳青霉烯酶
Microb Drug Resist. 2016 Dec;22(8):627-637. doi: 10.1089/mdr.2015.0060. Epub 2016 Mar 22.
5
Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.日本碳青霉烯类药物不敏感不动杆菌属的分子特征:多重耐药鲍曼不动杆菌克隆复合体 92 和产 IMP 型金属β-内酰胺酶的非鲍曼不动杆菌种的优势。
J Infect Chemother. 2012 Aug;18(4):522-8. doi: 10.1007/s10156-012-0374-y. Epub 2012 Feb 14.
6
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.分析 ICU 患者下呼吸道感染的鲍曼不动杆菌分离株的表型和分子特征。
Microb Pathog. 2019 Mar;128:75-81. doi: 10.1016/j.micpath.2018.12.023. Epub 2018 Dec 15.
7
Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China.中国南方广东省耐碳青霉烯类鲍曼不动杆菌的分子流行病学和遗传特征。
J Glob Antimicrob Resist. 2019 Jun;17:84-89. doi: 10.1016/j.jgar.2018.11.002. Epub 2018 Nov 13.
8
Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.德国北莱茵-威斯特法伦州医院耐碳青霉烯类不动杆菌属的分子研究
Microb Drug Resist. 2017 Jan;23(1):25-31. doi: 10.1089/mdr.2016.0035. Epub 2016 Apr 19.
9
Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.在德黑兰住院的烧伤患者中,广泛存在携带不同碳青霉烯水解β-内酰胺酶基因的鲍曼不动杆菌克隆谱系 I 和 II。
J Infect Public Health. 2015 Nov-Dec;8(6):533-42. doi: 10.1016/j.jiph.2015.04.030. Epub 2015 Jun 22.
10
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.埃及一家三级护理医院耐碳青霉烯鲍曼不动杆菌的分子流行病学:blaOXA-23的克隆传播
Microb Drug Resist. 2018 Apr;24(3):269-277. doi: 10.1089/mdr.2017.0057. Epub 2017 Aug 7.

引用本文的文献

1
The global epidemiology of carbapenem-resistant .耐碳青霉烯类药物的全球流行病学情况
JAC Antimicrob Resist. 2025 Jul 29;7(4):dlaf134. doi: 10.1093/jacamr/dlaf134. eCollection 2025 Aug.
2
The fitness connection of antibiotic resistance.抗生素耐药性与健康的关联。
Front Microbiol. 2025 Apr 10;16:1556656. doi: 10.3389/fmicb.2025.1556656. eCollection 2025.
3
Molecular epidemiology and patient outcome of carbapenem-resistant and in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network.日本碳青霉烯耐药及多重耐药菌的分子流行病学与患者预后:来自多药耐药菌临床研究网络的一项多中心研究
JAC Antimicrob Resist. 2025 Mar 6;7(2):dlaf027. doi: 10.1093/jacamr/dlaf027. eCollection 2025 Apr.
4
Clonality and the Phenotype-Genotype Correlation of Antimicrobial Resistance in Isolates: A Multicenter Study of Clinical Isolates from Romania.分离株中抗菌药物耐药性的克隆性及表型-基因型相关性:罗马尼亚临床分离株的多中心研究
Microorganisms. 2025 Jan 16;13(1):176. doi: 10.3390/microorganisms13010176.
5
Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis.鲍曼不动杆菌对碳青霉烯类耐药的地理分布及时间趋势:一项综合荟萃分析。
PLoS One. 2024 Dec 16;19(12):e0311124. doi: 10.1371/journal.pone.0311124. eCollection 2024.
6
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.ESKAPE 病原体:抗微生物药物耐药性、流行病学、临床影响和治疗学。
Nat Rev Microbiol. 2024 Oct;22(10):598-616. doi: 10.1038/s41579-024-01054-w. Epub 2024 Jun 3.
7
Type IV Pilus-Mediated Inhibition of Biofilm Formation by Phenothiazine Compounds.苯并噻嗪类化合物通过 IV 型菌毛抑制生物膜形成。
Microbiol Spectr. 2023 Aug 17;11(4):e0102323. doi: 10.1128/spectrum.01023-23. Epub 2023 Jun 21.
8
High Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Isolates Recovered in Nigerian Hospitals in 2016 to 2020.2016 年至 2020 年尼日利亚医院分离的耐碳青霉烯鲍曼不动杆菌的高遗传多样性。
mSphere. 2023 Jun 22;8(3):e0009823. doi: 10.1128/msphere.00098-23. Epub 2023 Apr 17.
9
Molecular typing and antibiotic resistance patterns among clinical isolates of recovered from burn patients in Tehran, Iran.从伊朗德黑兰烧伤患者中分离出的临床分离株的分子分型和抗生素耐药模式。
Front Microbiol. 2022 Oct 21;13:994303. doi: 10.3389/fmicb.2022.994303. eCollection 2022.
10
Antibacterial Activity of Imipenem/Relebactam against Clinical Isolates in Japan.亚胺培南/雷巴他定对日本临床分离株的抗菌活性。
Microbiol Spectr. 2022 Apr 27;10(2):e0223521. doi: 10.1128/spectrum.02235-21. Epub 2022 Apr 13.

本文引用的文献

1
A glimpse into evolution and dissemination of multidrug-resistant Acinetobacter baumannii isolates in East Asia: a comparative genomics study.东亚地区多重耐药鲍曼不动杆菌分离株的进化与传播窥探:一项比较基因组学研究
Sci Rep. 2016 Apr 13;6:24342. doi: 10.1038/srep24342.
2
Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.两种多位点序列分型(MLST)方案用于鲍曼不动杆菌暴发株和散发株特征鉴定的直接比较
PLoS One. 2016 Apr 12;11(4):e0153014. doi: 10.1371/journal.pone.0153014. eCollection 2016.
3
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.尼泊尔一家大学医院多重耐药鲍曼不动杆菌分离株的分子流行病学研究显示出一种新型流行克隆谱系的出现。
Int J Antimicrob Agents. 2015 Nov;46(5):526-31. doi: 10.1016/j.ijantimicag.2015.07.012. Epub 2015 Aug 28.
4
A Epidemiological Investigation of a Nosocomial Outbreak of Multidrug-Resistant Acinetobacter baumannii in a Critical Care Center in Japan, 2011-2012.2011 - 2012年日本一家重症监护中心耐多药鲍曼不动杆菌医院感染暴发的流行病学调查
Jpn J Infect Dis. 2016;69(2):143-8. doi: 10.7883/yoken.JJID.2015.049. Epub 2015 Jun 12.
5
Spread of OXA-23-producing Acinetobacter baumannii ST2 and ST246 in a hospital in Japan.产OXA-23型鲍曼不动杆菌ST2和ST246在日本一家医院的传播。
J Med Microbiol. 2015 Jul;64(7):739-744. doi: 10.1099/jmm.0.000077. Epub 2015 May 1.
6
Genotyping of Acinetobacter baumannii strains isolated at a Japanese hospital over five years using targeted next-generation sequencing.使用靶向二代测序技术对一家日本医院五年间分离出的鲍曼不动杆菌菌株进行基因分型。
J Infect Chemother. 2015 Jul;21(7):512-5. doi: 10.1016/j.jiac.2015.03.009. Epub 2015 Mar 20.
7
Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and Oceania.亚洲和大洋洲不动杆菌属对碳青霉烯类耐药的分子流行病学及机制
Microb Drug Resist. 2015 Aug;21(4):424-34. doi: 10.1089/mdr.2014.0234. Epub 2015 Feb 25.
8
An outbreak of blaOXA-51-like- and blaOXA-66-positive Acinetobacter baumannii ST208 in the emergency intensive care unit.鲍曼不动杆菌 ST208 型 blaOXA-51 样和 blaOXA-66 阳性爆发于急诊重症监护病房。
J Med Microbiol. 2014 Nov;63(Pt 11):1517-1523. doi: 10.1099/jmm.0.077503-0. Epub 2014 Aug 20.
9
Increase in the Prevalence of Carbapenem-Resistant Acinetobacter Isolates and Ampicillin-Resistant Non-Typhoidal Salmonella Species in Korea: A KONSAR Study Conducted in 2011.韩国耐碳青霉烯类不动杆菌分离株和耐氨苄西林非伤寒沙门氏菌物种患病率的增加:2011年进行的一项韩国全国抗菌药物耐药性监测(KONSAR)研究
Infect Chemother. 2014 Jun;46(2):84-93. doi: 10.3947/ic.2014.46.2.84. Epub 2014 Jun 20.
10
Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study.长期护理机构中多重耐药菌的流行情况及携带的危险因素:一项巢式病例对照研究。
J Antimicrob Chemother. 2014 Jul;69(7):1972-80. doi: 10.1093/jac/dku077. Epub 2014 Apr 7.

日本鲍曼不动杆菌国际克隆 II 谱系的分布和分子特征。

Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.

机构信息

Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan

Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

出版信息

Antimicrob Agents Chemother. 2018 Jan 25;62(2). doi: 10.1128/AAC.02190-17. Print 2018 Feb.

DOI:10.1128/AAC.02190-17
PMID:29203489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5786803/
Abstract

Multidrug-resistant (MDR) spp. have been globally disseminated in association with the successful clonal lineage international clone II (IC II). Because the prevalence of MDR spp. in Japan remains very low, we characterized all spp. ( = 866) from 76 hospitals between October 2012 and March 2013 to describe the entire molecular epidemiology of spp. The most prevalent species was ( = 645; 74.5%), with IC II ( = 245) accounting for 28.3% of the total. Meropenem-resistant isolates accounted for 2.0% ( = 17) and carried IS ( = 10), ( = 4), or IS ( = 3). Multilocus sequence typing of 110 representative isolates revealed the considerable prevalence of domestic sequence types (STs). IC II isolates were divided into the domestic sequence type 469 (ST469) ( = 18) and the globally disseminated STs ST208 ( = 14) and ST219 ( = 4). ST469 isolates were susceptible to more antimicrobial agents, while ST208 and ST219 overproduced the intrinsic AmpC β-lactamase. IC II and some non-IC II STs (e.g., ST149 and ST246) were associated with fluoroquinolone resistance. This study revealed that carbapenem-susceptible IC II was moderately disseminated in Japan. The low prevalence of acquired carbapenemase genes and presence of domestic STs could contribute to the low prevalence of MDR A similar epidemiology might have appeared before the global dissemination of MDR epidemic lineages. In addition, fluoroquinolone resistance associated with IC II may provide insight into the significance of epidemic clones.

摘要

耐多药(MDR) spp. 已在全球范围内传播,与成功的克隆谱系国际克隆 II(IC II)有关。由于日本 MDR spp. 的流行率仍然非常低,我们对 2012 年 10 月至 2013 年 3 月期间 76 家医院的所有 spp.(=866)进行了特征描述,以描述 spp. 的整个分子流行病学。最常见的物种是 (=645;74.5%),其中 IC II(=245)占总数的 28.3%。耐美罗培南分离株占 2.0%(=17),携带 IS(=10)、(=4)或 IS(=3)。110 株代表性 株的多位点序列分型显示出相当数量的国内序列型(STs)。IC II 分离株分为国内序列型 469(ST469)(=18)和全球传播的 ST208(=14)和 ST219(=4)。ST469 分离株对更多抗菌药物敏感,而 ST208 和 ST219 过度产生固有 AmpC β-内酰胺酶。IC II 和一些非 IC II STs(如 ST149 和 ST246)与氟喹诺酮耐药有关。本研究表明,耐碳青霉烯的 IC II 在日本中度传播。获得性碳青霉烯酶基因的低流行率和国内 STs 的存在可能导致 MDR 的低流行率。这种类似的流行病学可能在 MDR 流行谱系的全球传播之前就已经出现。此外,与 IC II 相关的氟喹诺酮耐药可能提供了对流行克隆重要性的深入了解。